You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 16, 2025

Details for Patent: 10,653,899


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,653,899 protect, and when does it expire?

Patent 10,653,899 protects TWYNEO and is included in one NDA.

This patent has fourteen patent family members in twelve countries.

Summary for Patent: 10,653,899
Title:Core stabilized microcapsules, method of their preparation and uses thereof
Abstract: The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within an inorganic oxide shell, processes for their preparations, comparisons comprising them and uses thereof.
Inventor(s): Toledano; Ofer (Kfar Saba, IL), Bar-Simantov; Haim (Netanya, IL), Sertchook; Hanan (Gedera, IL), Fireman-Shoresh; Sharon (Tel Aviv, IL), Marco; Dorit (Rehovot, IL)
Assignee: SOL-GEL TECHNOLOGIES LTD. (Ness Ziona, IL)
Application Number:16/052,635
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,653,899: A Comprehensive Analysis

Introduction

Patent 10,653,899, though not specifically detailed in the provided sources, can be analyzed using general principles of patent law, the structure of patent claims, and the current landscape of patent eligibility. This article will delve into the key aspects of patent claims, the patent landscape, and how these elements apply to any patent, including the hypothetical analysis of U.S. Patent 10,653,899.

Patent Claims: Structure and Importance

What are Patent Claims?

Patent claims define the scope of protection granted by a patent. They are the legal boundaries that distinguish the invention from prior art and other existing technologies[3].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim or another dependent claim.
  • Method Claims: Describe a process or method.
  • Apparatus Claims: Describe a device or system.
  • Composition of Matter Claims: Describe a chemical or biological composition[3].

Patent Scope and Measurements

Patent Scope

The scope of a patent is determined by its claims. The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including claim-level statistics and document-level statistics. This dataset helps in understanding the breadth and depth of patent protection[3].

Measuring Patent Scope

Researchers use various metrics to measure patent scope, such as the number of claims, claim length, and dependency relationships between claims. These metrics can indicate the complexity and breadth of the invention[3].

Patent Eligibility Under 35 U.S.C. ยง 101

Abstract Ideas and Natural Phenomena

The Supreme Court has established that laws of nature, natural phenomena, and abstract ideas are not patentable. The "Alice test" is a two-step framework used to determine if a claim is directed to an abstract idea and if it contains an inventive step that transforms the abstract idea into a patent-eligible invention[2].

Application to AI and Software Patents

Recent USPTO guidance updates have refined the process for determining the patent eligibility of AI-related inventions. This guidance includes examples of patent-eligible and ineligible claims, helping practitioners draft claims that avoid common section 101 rejections[4].

Obviousness-Type Double Patenting (ODP)

Definition and Implications

ODP is a doctrine that prevents the granting of multiple patents for the same invention or obvious variations of the same invention. This doctrine is crucial in ensuring that patentees do not extend the term of their patents indefinitely by filing multiple applications for slightly different versions of the same invention[1].

Case Example: In re Cellect

The case of In re Cellect illustrates how ODP can invalidate claims across a family of patents. Here, multiple patents were found to be unpatentable over each other due to ODP, highlighting the importance of careful patent strategy and the potential consequences of not addressing ODP during prosecution[1].

Small Claims Patent Court: Future Directions

Need for a Small Claims Court

There is ongoing discussion about the feasibility of a small claims patent court to address the high costs and complexity of patent litigation. This initiative aims to provide a more accessible and efficient forum for resolving patent disputes, particularly for small inventors and businesses[5].

Patent Term Adjustments and Extensions

Patent Term Adjustment (PTA)

PTA is granted for delays during the prosecution process. However, these adjustments must be carefully managed to avoid issues with ODP and to ensure that the patent term is not extended beyond what is legally permissible[1].

Patent Term Extension (PTE)

PTE can be granted under specific conditions, such as delays due to regulatory review. However, these extensions do not affect the validity of the patent under ODP, as seen in the Novartis AG v. Ezra Ventures LLC case[1].

Key Takeaways

  • Patent Claims: Define the scope of protection and are crucial for distinguishing the invention from prior art.
  • Patent Scope: Measured using various metrics, including claim count and dependency relationships.
  • Patent Eligibility: Subject to the "Alice test" for abstract ideas and recent USPTO guidance for AI-related inventions.
  • ODP: Prevents the granting of multiple patents for the same or obvious variations of the same invention.
  • Small Claims Court: A proposed initiative to make patent litigation more accessible and efficient.
  • Patent Term Adjustments: Granted for prosecution delays but must be managed carefully to avoid ODP issues.

FAQs

What is the purpose of patent claims?

Patent claims define the legal boundaries of an invention, distinguishing it from prior art and other technologies.

How is patent scope measured?

Patent scope is measured using metrics such as the number of claims, claim length, and dependency relationships between claims.

What is the "Alice test" in patent law?

The "Alice test" is a two-step framework used to determine if a claim is directed to an abstract idea and if it contains an inventive step that transforms the abstract idea into a patent-eligible invention.

What is Obviousness-Type Double Patenting (ODP)?

ODP is a doctrine that prevents the granting of multiple patents for the same invention or obvious variations of the same invention.

Why is there a need for a small claims patent court?

A small claims patent court is proposed to provide a more accessible and efficient forum for resolving patent disputes, particularly for small inventors and businesses.

How do Patent Term Adjustments (PTA) work?

PTA is granted for delays during the prosecution process, but these adjustments must be carefully managed to avoid issues with ODP.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Broadband iTV, Inc. v. Amazon.com, Inc., United States Court of Appeals for the Federal Circuit, September 3, 2024.
  3. Patent Claims Research Dataset, USPTO, August 28, 2017.
  4. Understanding the 2024 USPTO Guidance Update on AI Patent, Mintz, July 25, 2024.
  5. U.S. Patent Small Claims Court, Administrative Conference of the United States, accessed December 22, 2024.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,653,899

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs Lp TWYNEO benzoyl peroxide; tretinoin CREAM;TOPICAL 214902-001 Jul 26, 2021 RX Yes Yes 10,653,899 ⤷  Try for Free Y TOPICAL TREATMENT OF ACNE VULGARIS IN ADULTS AND PEDIATRIC PATIENTS 9 YEARS OF AGE AND OLDER ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.